# Tesamorelin Reconstitution and Dosing: What Labeled Use and Papers Report
> Note: PeptIQ is not a medical provider. This article is educational only. Labeled product instructions and published figures are not advice to obtain or use a research vial.
Tesamorelin is a stabilized analog of growth hormone-releasing hormone. The FDA approved a branded product (Egrifta) for reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. Spooner and Olin reviewed that indication and the daily clinical frame (PubMed 22298602). A StatPearls-style tesamorelin monograph also sits in the corpus (PubMed 31644039). ClinicalTrials.gov indexes the lipodystrophy program (search).
That labeled history is why tesamorelin dose conversations look more "official" than BPC-157 threads. The official number still belongs to a specific formulation, diluent, and indication.
Evidence tier
| Layer | What it supports | What it does not |
|---|---|---|
| FDA-labeled product | 2 mg subcutaneous daily in the approved HIV-lipodystrophy setting, per that product's instructions | A research-vial protocol for other goals |
| Phase III VAT trials | Visceral adipose and IGF-1 changes under study supply | Identity of an unlabeled powder |
| Community wellness logs | Off-label curiosity and tracking habits | Medical endorsement |
First split: branded kit versus lyophilized listing
| What someone is holding | What reconstitution usually means |
|---|---|
| Branded tesamorelin kit | Follow the exact instructions for use. Diluent, volume, and beyond-use dating are product-specific. |
| Compounded pharmacy syringe or vial | Ask the pharmacy for concentration and dating. Do not import a forum chart. |
| Gray-market lyophilized "tesamorelin" | Identity, fill weight, and salt form may be wrong. Math assumes a true label. |
If the product is already in a dual-chamber device or pharmacy-prepared syringe, there is nothing to "reconstitute" from a 2 mL BAC-water habit.
Educational math for lyophilized listings only
When people apply generic peptide arithmetic to a claimed tesamorelin vial, they use:
Concentration (mg/mL) = labeled mg ÷ diluent mL
